Keywords: China, Sinovac, Vaccines, Hepatitis, Investment, Production capacity

China’s Sinovac completes acquisition aimed at expanding production capacity

Article | 16 February 2010

Sinovac Biotech, a leading China-based vaccine manufacturer, has announced the completion by its subsidiary, Sinovac Beijing, of the acquisition of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Alpha

Prolastin

Go to drug listing